Fund Description: ETFMG Treatments, Testing and Advancements ETF, is an exchange-traded index fund or Index ETF which is a separate investment portfolio of the ETF Managers Trust, formerly FactorShares Trust, an open-end investment management company. <p> INVESTMENT OBJECTIVE: The ETFMG Treatments, Testing and Advancements ETF seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Prime Treatments, Testing and Advancements Index. <p> INDEX DESCRIPTION: The Prime Treatments, Testing and Advancements Index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The Index is comprised of two groups of companies, Treatment Companies and Testing Companies. “Treatment Companies” are companies that (i) have one or more vaccines or treatments for infectious diseases in pre-clinical research, in any phase of U.S. Food and Drug Administration clinical trials, or in a commercial stage and (ii) are classified by the North American Industry Classification System as either “Pharmaceutical and Medicine Manufacturing” or “Research and Development in the Physical, Engineering, and Life Sciences”. “Testing Companies” are companies that derive more than 50% of their revenue from the research, development, manufacturing, and provision of biological tests for patients. <p> FUND STRATEGY: The Fund uses a passive or indexing approach to try to achieve the Fund’s investment objective. Unlike many investment companies, the Fund does not try to beat the Index and does not seek temporary defensive positions when markets decline or appear overvalued. The Fund will use a replication strategy which is an indexing strategy that involves investing in the securities of the Index in approximately the same proportions as in the Index. However, the Fund may utilize a representative sampling strategy with respect to the Index when a replication strategy might be detrimental to shareholders. The Fund normally invests at least 80% of its total assets in securities <p> FUND MANAGEMENT: ETF Managers Group LLC serves as the investment adviser to the fund.